Atria Wealth Solutions’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-9,709	Closed	-$686K	–	1508
2025 Q1	$686K	Buy	+9,709	New	+$653K	0.01%	1045
2024 Q3	–	Sell	-2,542	Closed	-$209K	–	1930
2024 Q2	$209K	Sell	2,542 -7,296	-74%	-$607K	﹤0.01%	1747
2024 Q1	$859K	Buy	9,838 +109	+1%	+$9.76K	0.01%	977
2023 Q4	$938K	Buy	9,729 +153	+2%	+$13.5K	0.01%	889
2023 Q3	$847K	Buy	9,576 +461	+5%	+$41K	0.01%	888
2023 Q2	$790K	Buy	9,115 +631	+7%	+$59.4K	0.01%	949
2023 Q1	$825K	Buy	8,484 +1,566	+23%	+$162K	0.01%	874
2022 Q4	$716K	Sell	6,918 -176	-2%	-$16.5K	0.01%	914
2022 Q3	$601K	Sell	7,094 -3,224	-31%	-$287K	0.01%	928
2022 Q2	$855K	Buy	10,318 +2,206	+27%	+$176K	0.02%	757
2022 Q1	$625K	Buy	+8,112	New	+$679K	0.01%	940